Monday, September 25, 2017

Review Finds Little Evidence that Electroconvulsive Therapy is Effective for Depression

Researchers examined the dearth of support for Electroconvulsive therapy (ECT) for depressive symptoms in light of studies detailing the associated risks.

Leading Researchers Critique Current Paradigm for Studying ‘Schizophrenia’ Risk

Re-conceptualizing the Clinical-High-Risk/Ultra-High-Risk Paradigm: A critique and reappraisal
christ

Thou Shall Not Criticize Our Drugs

A medical journal is expected to promote an open-minded discussion of treatments, even if findings—or criticisms—threaten conventional beliefs. But the American Journal of Psychiatry will not find space for criticism even if it comes from one of the best-known psychiatrists in the world.

What Happens When You Stop Taking Psychiatric Medications

From Pacific Standard: A new study surveyed people who have come off psychiatric medications to come up with information doctors can use to help support their...
elephant

Psychiatry Ignores an Elephant in the Room

Large cohort studies of people with a first-episode psychosis provide a unique opportunity for finding out why so many young people with schizophrenia spectrum disorders die at a young age. However, it seems that those psychiatrists who have access to the mortality data generally do not want the facts to come out.

Renowned Psychiatrist Warns That Trump is a Danger to Us All

From Alternet: A new book, The Dangerous Case of Donald Trump, written by 27 psychiatrists, psychologists, and mental health experts to warn the public of President Trump's...

Replacing Pain with Pain: Hazards of Antidepressant Use for Chronic Pain Relief

The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).

Lawsuit Over a Suicide Points to a Risk of Antidepressants

From The New York Times: The recent trial of Wendy Dolin, whose husband died of suicide after starting the antidepressant paroxetine, demonstrates our need for more...

Why do People Self-Harm? You Asked – Here’s the Answer

In this piece for The Guardian, Jay Watts explores the social and societal factors that often lead to self-harm and explains how psychiatric labeling can exacerbate self-harm. "Self-harm...

The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds

Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.

Reflections on the Cruel and Subtle Costs of Racism and Bigotry

In this essay for the Psychiatric Times, Dr. Edward Khantzian reflects on the pain and grief caused by all forms of racism and bigotry, from...

The Smartphone Psychiatrist

In this piece for The Atlantic, David Dobbs delves into the life of former NIMH director Thomas Insel, his critiques of research within the field of...

Trauma-Ignored Care? Going to the MAT on Opioids

Our current, reductionistic approach to mental health issues doesn’t offer any insights or explanations on the etiology of most mental disturbances. Similarly, medication assisted treatment (MAT) focuses on the surface symptoms of opiate abuse without addressing the underlying causes of overwhelming distress and pain.

Disturbed Sleep Patterns May be Key to ADHD

From The Guardian: New research has linked symptoms of ADHD, such as struggling to concentrate, having too much energy, and being unable to control behavior,...

Proove Biosciences Sells Off Assets as CEO Departs

From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...

Good Psychologist, Bad Psychologist

In this episode on BBC Radio, psychiatrist Raj Persaud reports on the CIA's so-called "enhanced interrogation" program, which has frequently been characterized as torture. He discusses...

MDMA Crossed a Hurdle on the Path to Being Legally Prescribed

From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....

Researchers Question Add-On Treatment for ‘Schizophrenia’

A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.

Why Addiction Language is Harmful

In this video for Benzo Brains, Jocelyn Pedersen explains why addiction is harmful to benzodiazepine survivors and differentiates benzodiazepine associated disability (BAD) from benzodiazepine addiction.

Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities

One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.

The Real Opioid Emergency

From The New York Times: In recent years, politicians have shown increased awareness of the opioid epidemic and have made statements about the need for treatment,...

The Concept of Schizophrenia is Coming to an End – Here’s Why

From The Conversation: Many researchers are beginning to acknowledge that the concept of "schizophrenia" as a discrete, hopeless, and deteriorating brain disease does not exist. In...

Google Will Now Ask Users: “Are You Depressed?”

From Yahoo! Finance: Google is launching a new search feature that will help check whether users are depressed. People who make depression-related queries will now...

Abilify: The Drug That Could Gamble Your Life Away

On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...

Time on a Therapist’s Couch Yields Personality Changes

From Ars Technica: A recent meta-analysis found that a variety of different therapeutic techniques result in positive personality changes. The two personality traits most impacted...

Follow Us

19,372FansLike
10,223FollowersFollow
1,371SubscribersSubscribe